Research Article
Epidemiology and Virulence Determinants including Biofilm Profile of Candida Infections in an ICU in a Tertiary Hospital in India
Table 3
The in vitro antifungal susceptibilities of Candida isolates to fluconazole and amphotericin B.
| Species
(no. of isolates) | Antifungal drug susceptibility pattern | | Fluconazole | Amphotericin B | Sa (≤8 g/mL)
no. (%) | SDDb (16–32 g/mL)
no. (%) | Rc (≥64 g/mL)
no. (%) | Sa (≤1 g/mL)
no. (%) | Rc (≥1 g/mL)
no. (%) |
| | C. albicans (40) | 10 (25%) | 3 (7.5%) | 27 (67.5%) | 38 (95%) | 2 (5%) | | C. tropicalis (42) | 15 (35.7%) | 3 (7.1%) | 24 (57.2%) | 40 (95.2%) | 2 (4.8%) | | C. glabrata (11) | 6 (54.5%) | 0 | 5 (45.5%) | 10 (90.9%) | 1 (9.1%) | | C. sphaerica (02) | 1 (50%) | 0 | 1 (50%) | 2 (100%) | 0 | | C. parapsilosis (04) | 2 (50%) | 0 | 2 (50%) | 4 (100%) | 0 | | C. kefyr (02) | 2 (100%) | 0 | 0 | 2 (100%) | 0 | | C. krusei (02) | 0 | 1 (50%) | 1 (50%) | 0 | 2 (100%) |
|
|
Sa: susceptible range.
SDDb: susceptible dose-dependent range.
Rc: resistant range.
|
